Xiaodong Cheng
11Patents
1h-index
23Co-inventors
50Inventor score
Filing activity: Feb 13, 2007 → Feb 22, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10934365B2 | Anti-OX40 antibodies and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US9539256B2 | Modulators of exchange proteins directly activated by cAMP (EPACS) | Human Necessities | 1 | Active |
| US11034764B2 | Anti-CTLA4 antibodies and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US9458131B2 | Compounds and compositions used to epigenetically transform cells and methods related thereto | Chemistry; Metallurgy | 1 | Active |
| US11999790B2 | Anti-OX40 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11124489B2 | EPAC antagonists | Emerging Cross-Sectional Technologies | 0 | Active |
| US11001632B2 | Anti-CTLA4 antibodies and uses thereof | General | 0 | Revoked |
| US9737512B2 | Methods and compositions for treating chronic pain | Human Necessities | 0 | Active |
| US7897340B2 | Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic marker | Chemistry; Metallurgy | 0 | Active |
| US11155625B2 | Anti-PD-1 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12054547B2 | Anti-CTLA4 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.